5-[2-[[(4-Methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]cyclopentanol structure
|
Common Name | 5-[2-[[(4-Methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]cyclopentanol | ||
---|---|---|---|---|
CAS Number | 142217-78-5 | Molecular Weight | 823.976 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C52H49N5O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol |
---|---|
Synonym | More Synonyms |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C52H49N5O5 |
Molecular Weight | 823.976 |
Exact Mass | 823.373352 |
PSA | 112.78000 |
LogP | 9.99 |
Index of Refraction | 1.646 |
Hazard Codes | Xn |
---|
~84% 5-[2-[[(4-Metho... CAS#:142217-78-5 |
Literature: Bisacchi; Chao; Bachard; Daris; Innaimo; Jacobs; Kocy; Lapointe; Martel; Merchant; Slusarchyk; Sundeen; Young; Colonno; Zahler Bioorganic and Medicinal Chemistry Letters, 1997 , vol. 7, # 2 p. 127 - 132 |
~% 5-[2-[[(4-Metho... CAS#:142217-78-5 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
~% 5-[2-[[(4-Metho... CAS#:142217-78-5 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
~% 5-[2-[[(4-Metho... CAS#:142217-78-5 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
~% 5-[2-[[(4-Metho... CAS#:142217-78-5 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
~% 5-[2-[[(4-Metho... CAS#:142217-78-5 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
~% 5-[2-[[(4-Metho... CAS#:142217-78-5 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 2 p. 127 - 132 |
(2R,3S,5S)-3-(Benzyloxy)-5-[6-(benzyloxy)-2-{[(4-methoxyphenyl)(diphenyl)methyl]amino}-9H-purin-9-yl]-2-[(benzyloxy)methyl]cyclopentanol |
Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (2R,3S,5S)- |
Entecavir-5 |
Entecavir InterMediate V |
(1S,3R,4S)-3-(benzyloxy-5-[6-(benzyloxy)-2 -((4-Methoxyphenyl)diphenylMethylaMino) -9H-purin-9-yl]-2-(benzyloxyMethyl)cyclopentanol |
(2R,3S,5S)-3-(Benzyloxy)-5-(6-benzyloxy)-2-(4-methyoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-benzyloxymethyl)cyclopentanol |
(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-Methoxyphenyl)diphenylMethyl)aMino)-9H-purin-9-yl)-2-((benzyloxy)Methyl)cyclopentanol |
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9 |
(1S,2S,3S,5S)-3-(Benzyloxy)-5-[6-(benzyloxy)-2-{[(4-methoxyphenyl)(diphenyl)methyl]amino}-9H-purin-9-yl]-2-[(benzyloxy)methyl]cyclopentanol |
Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)- |
(1S,2S,3S,5S)-5-(2-((4-Methoxyphenyl)diphenylMethylaMino)-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-((benzyloxy)Methyl)cyclopentanol |
Entecavir InterMediate ( # ) |
Entecavir Impurity 13 |